Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2026 11:00 ET | Source: Genovyn Inc.

Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development

Genovyn appoints biotech leaders Sammy Bell, Ph.D., as CSO and Jim Edinger, Ph.D., as CDO to advance AI-enabled discovery.